<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34062184</PMID><DateCompleted><Year>2021</Year><Month>09</Month><Day>06</Day></DateCompleted><DateRevised><Year>2022</Year><Month>07</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-2742</ISSN><JournalIssue CitedMedium="Internet"><Volume>83</Volume><Issue>3</Issue><PubDate><Year>2021</Year><Month>Sep</Month></PubDate></JournalIssue><Title>The Journal of infection</Title><ISOAbbreviation>J Infect</ISOAbbreviation></Journal><ArticleTitle>Previous COVID-19 infection, but not Long-COVID, is associated with increased adverse events following BNT162b2/Pfizer vaccination.</ArticleTitle><Pagination><StartPage>381</StartPage><EndPage>412</EndPage><MedlinePgn>381-412</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jinf.2021.05.035</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0163-4453(21)00277-2</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Raw</LastName><ForeName>Rachael Kathleen</ForeName><Initials>RK</Initials><AffiliationInfo><Affiliation>Newcastle University, United Kingdom; James Cook Universiry Hospital, United Kingdom. Electronic address: rachael.raw3@nhs.net.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kelly</LastName><ForeName>Clive Anthony</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>James Cook Universiry Hospital, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rees</LastName><ForeName>Jon</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>University of Sunderland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wroe</LastName><ForeName>Caroline</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>James Cook Universiry Hospital, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chadwick</LastName><ForeName>David Robert</ForeName><Initials>DR</Initials><AffiliationInfo><Affiliation>James Cook Universiry Hospital, United Kingdom.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016420">Comment</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>05</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Infect</MedlineTA><NlmUniqueID>7908424</NlmUniqueID><ISSNLinking>0163-4453</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance></Chemical><Chemical><RegistryNumber>N38TVC63NU</RegistryNumber><NameOfSubstance UI="D000090982">BNT162 Vaccine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentOn"><RefSource>J Infect. 2021 Aug;83(2):237-279. doi: 10.1016/j.jinf.2021.03.025</RefSource><PMID Version="1">33811939</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000090982" MajorTopicYN="N">BNT162 Vaccine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086663" MajorTopicYN="N">COVID-19 Vaccines</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Declarations of Competing Interest No conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>5</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>5</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>6</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>6</Month><Day>1</Day><Hour>20</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>5</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34062184</ArticleId><ArticleId IdType="pmc">PMC8164507</ArticleId><ArticleId IdType="doi">10.1016/j.jinf.2021.05.035</ArticleId><ArticleId IdType="pii">S0163-4453(21)00277-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Tr&#xe9;-Hardy M., Cupaiolo R., Papleux E., et al. Reactogenicity, safety and antibody response, after one and two doses of mRNA-1273 in seronegative and seropositive healthcare workers. J Infect. 2021 doi: 10.1016/j.jinf.2021.03.025. Article in press.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2021.03.025</ArticleId><ArticleId IdType="pmc">PMC8012163</ArticleId><ArticleId IdType="pubmed">33811939</ArticleId></ArticleIdList></Reference><Reference><Citation>Krammer F., Srivastava K., Marks F., et al. Robust spike antibody responses and increased reactogenicity in seropositive individuals after a 1 single dose of SARS-CoV-2 mRNA vaccine. MedRxiv. 2021 doi: 10.1101/2021.01.29.21250653. 2021.01.29.21250653.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.01.29.21250653</ArticleId></ArticleIdList></Reference><Reference><Citation>Kings College London COVID Symptom Study. Here's what we know so far about the after effects of the Pfizer COVID vaccine. 2021. https://covid.joinzoe.com/post/covid-vaccine-pfizer-effects (accessed Feb 5, 2021).</Citation></Reference><Reference><Citation>Mathioudakis A.G., Ghrew M., Ustianowski A. et&#xa0;al. Self-reported real-world safety and reactogenicity of COVID-19 vaccines: an international vaccine-recipient survey. MedRxiv 2021; 2021.02.26.21252096. doi: 10.1101/2021.02.26.21252096.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8002738</ArticleId><ArticleId IdType="pubmed">33803014</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A., Bernabei R., Landi F. Gemelli against COVID-19 post-acute care study group. persistent symptoms in patients after acute COVID-19. JAMA. 2020;324(6):603&#x2013;605. doi: 10.1001/jama.2020.12603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Barello S., Nania T., Dellafiore F., Graffigna G., Caruso R. Vaccine hesitancy' among university students in Italy during the COVID-19 pandemic. Eur J Epidemiol. 2020;35(8):781&#x2013;783. doi: 10.1007/s10654-020-00670-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10654-020-00670-z</ArticleId><ArticleId IdType="pmc">PMC7409616</ArticleId><ArticleId IdType="pubmed">32761440</ArticleId></ArticleIdList></Reference><Reference><Citation>Food and Drug Administration. Guidance for industry toxicity grading scale for healthy adult and adolescent volunteers enrolled in preventive vaccine clinical trials. 2021. https://www.fda.gov/media/73679/download (accessed Feb 5, 2021).</Citation></Reference><Reference><Citation>Manisty C., Otter A.D., Treibel T.A., et al. Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals. Lancet. 2021;397:1057&#x2013;1058. doi: 10.1016/S0140-6736(21)00501-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)00501-8</ArticleId><ArticleId IdType="pmc">PMC7972310</ArticleId><ArticleId IdType="pubmed">33640038</ArticleId></ArticleIdList></Reference><Reference><Citation>Shields A., Faustini S.E., Perez-Toledo M., et al. SARS-CoV-2 seroprevalence and asymptomatic viral carriage in healthcare workers: a cross-sectional study. Thorax. 2020;75(12):1089&#x2013;1094. doi: 10.1136/thoraxjnl-2020-215414.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-215414</ArticleId><ArticleId IdType="pmc">PMC7462045</ArticleId><ArticleId IdType="pubmed">32917840</ArticleId></ArticleIdList></Reference><Reference><Citation>Sax L.J., Gilmartin S.K., Bryant A.N. Assessing response rates and nonresponse bias in web and paper surveys. Res High Edu. 2003;44(4):409&#x2013;432. doi: 10.1016/j.sapharm.2006.10.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.sapharm.2006.10.001</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>